Clinical Pharmacology and Drug Toxicity — MCQs
On this page
What is the ideal chelating agent in a patient with G6PD deficiency?
Which of the following is advocated in dicoumarol poisoning?
Hepatotoxicity caused by valproate can be prevented by?
As per the Drugs and Cosmetics Act, prescription drugs are included under which schedule?
What is a specific inhibitor of alcohol dehydrogenase?
A 61-year-old male with a history of chronic arthritis complains of pronounced tinnitus. He also has some dizziness, with headache. Physical examination reveals some scattered petechiae over the upper extremities. A stool guaiac test result is positive. Which of the following drug toxicities best explains these findings?
Phase IV of clinical trials collect information specifically about which of the following?
Fetal hydantoin syndrome is caused by which of the following agents?
Which chelating agent for copper, mercury, and lead poisoning is administered orally?
Which of the following is an antidote to acetaminophen poisoning?
Clinical Pharmacology and Drug Toxicity Indian Medical PG Practice Questions and MCQs
Question 191: What is the ideal chelating agent in a patient with G6PD deficiency?
- A. DMSA (Correct Answer)
- B. DMPS
- C. EDTA
- D. BAL
Explanation: The correct answer is **DMSA (Succimer)**. In patients with **G6PD deficiency**, the primary concern during chelation therapy is the risk of **oxidative stress**, which can trigger acute hemolysis. G6PD is essential for maintaining the pool of reduced glutathione, which protects erythrocytes from oxidative damage. **Why DMSA is the correct choice:** DMSA (Dimercaptosuccinic acid) is a water-soluble analogue of BAL. It is the preferred chelator in G6PD deficiency because it is **less likely to induce oxidative stress** compared to other agents [1]. It is also the only orally active chelator among the options and has a high therapeutic index, making it safer for pediatric use and patients with enzymatic deficiencies [1]. **Why the other options are incorrect:** * **BAL (British Anti-Lewisite/Dimercaprol):** This is strictly **contraindicated** in G6PD deficiency. BAL is known to cause significant oxidative stress and can precipitate severe **hemolysis** in these patients. It also requires painful intramuscular injections in a peanut oil base. * **DMPS:** While similar to DMSA, it is less commonly used and lacks the extensive safety profile of DMSA regarding G6PD-specific clinical data [1]. * **EDTA (Calcium Disodium):** Primarily used for lead poisoning, EDTA is a polar compound that can cause nephrotoxicity [2]. It does not specifically address the oxidative concerns of G6PD deficiency as effectively as DMSA. **High-Yield Clinical Pearls for NEET-PG:** * **DMSA (Succimer):** Drug of choice for oral chelation in lead, mercury, and arsenic poisoning [1]. * **BAL Contraindications:** G6PD deficiency, severe hepatic failure, and concurrent iron therapy (forms a toxic complex). * **Wilson’s Disease:** Penicillamine is the traditional DOC, but Trientine is preferred if the patient is intolerant. * **Iron Toxicity:** Desferrioxamine (IV) is the DOC; Deferiprone and Deferasirox are oral alternatives.
Question 192: Which of the following is advocated in dicoumarol poisoning?
- A. Warfarin
- B. Heparin
- C. LMWH
- D. Vitamin K (Correct Answer)
Explanation: **Explanation:** **Dicoumarol** is a naturally occurring anticoagulant that functions as a competitive inhibitor of **Vitamin K Epoxide Reductase (VKOR)**. Its mechanism of action is identical to Warfarin; it prevents the gamma-carboxylation of Vitamin K-dependent clotting factors (II, VII, IX, and X), leading to a state of functional Vitamin K deficiency and subsequent hemorrhage. **Why Vitamin K is the Correct Answer:** The physiological antidote for dicoumarol (and all coumarin derivatives) is **Vitamin K1 (Phytonadione)**. By providing exogenous Vitamin K, the body can bypass the inhibited VKOR enzyme and resume the synthesis of active clotting factors. In cases of severe life-threatening bleeding, Fresh Frozen Plasma (FFP) or Prothrombin Complex Concentrate (PCC) is administered for immediate effect, followed by Vitamin K for sustained reversal. **Why Other Options are Incorrect:** * **Warfarin (A):** This is another coumarin derivative with the same mechanism as dicoumarol. Administering it would exacerbate the toxicity and bleeding. * **Heparin (B) & LMWH (C):** These are parenteral anticoagulants that activate Antithrombin III. They would further increase the risk of hemorrhage and have no role in reversing the effects of dicoumarol. **High-Yield Clinical Pearls for NEET-PG:** * **Source:** Dicoumarol is found in "sweet clover" and is responsible for "sweet clover disease" in cattle. * **Monitoring:** The effect of dicoumarol/warfarin is monitored using **PT/INR** (Extrinsic pathway). * **Teratogenicity:** Coumarins are teratogenic (Fetal Warfarin Syndrome), causing bone abnormalities (stippled epiphyses) and nasal hypoplasia. * **Antidote Speed:** Vitamin K takes 6–24 hours to work (requires new protein synthesis). For **immediate** reversal, use **PCC** (preferred) or **FFP**.
Question 193: Hepatotoxicity caused by valproate can be prevented by?
- A. Zinc
- B. Carnitine (Correct Answer)
- C. Pyridoxine
- D. Vitamin K
Explanation: Explanation: Mechanism of Valproate-Induced Hepatotoxicity: Valproate (VPA) is a broad-spectrum antiepileptic that undergoes complex metabolism. A significant portion of its toxicity is attributed to the inhibition of fatty acid beta-oxidation in the mitochondria. VPA and its metabolites (like 4-en-VPA) deplete cellular stores of Carnitine, which is essential for transporting long-chain fatty acids into the mitochondria. This leads to mitochondrial dysfunction, microvesicular steatosis, and hyperammonemia. Supplementation with L-carnitine helps restore the carnitine pool, facilitates the removal of toxic VPA metabolites, and improves mitochondrial function, making it the specific antidote for VPA-induced hepatotoxicity and hyperammonemic encephalopathy. Analysis of Incorrect Options: A. Zinc: While Zinc is used in Wilson’s disease to prevent copper absorption, it has no established role in mitigating valproate toxicity. C. Pyridoxine (Vitamin B6): This is the antidote for Isoniazid (INH) induced peripheral neuropathy and seizures, but it does not prevent VPA-induced liver injury. D. Vitamin K: While Vitamin K is used to manage coagulopathy resulting from liver failure, it does not prevent the underlying hepatotoxic process caused by valproate. High-Yield Clinical Pearls for NEET-PG: Risk Factors: Children under 2 years old on polytherapy are at the highest risk for VPA hepatotoxicity (Fulp-like syndrome). Hyperammonemia: VPA can cause elevated ammonia levels even without deranged liver enzymes; Carnitine is effective here as well. Other Side Effects of VPA: Weight gain, Alopecia (regrowth is curly), Polycystic Ovarian Syndrome (PCOS), and Teratogenicity (Neural tube defects/Spina bifida).
Question 194: As per the Drugs and Cosmetics Act, prescription drugs are included under which schedule?
- A. Schedule C
- B. Schedule H (Correct Answer)
- C. Schedule P
- D. Schedule X
Explanation: ### Explanation **Correct Answer: B. Schedule H** In India, the **Drugs and Cosmetics Act (1940)** and Rules (1945) regulate the manufacture, sale, and distribution of drugs. **Schedule H** specifically lists "Prescription Drugs." These drugs cannot be sold over the counter (OTC) and must be dispensed only against a valid prescription from a Registered Medical Practitioner (RMP). The drug container must also carry a warning label with the symbol **Rx**. **Analysis of Incorrect Options:** * **Schedule C (and C1):** Relates to **Biological and Special Products**, such as serums, vaccines, insulin, and parenteral drugs [1]. These have specific requirements for storage and import. * **Schedule P:** Dictates the **Life period (Expiry date)** and storage conditions of drugs. For example, it specifies how long a particular antibiotic or vaccine remains potent. * **Schedule X:** Includes **Narcotic and Psychotropic substances** that have a high potential for abuse (e.g., Ketamine, Amphetamines). These require special "triple-copy" prescriptions, and the pharmacist must retain a copy for two years. They are labeled with the symbol **XRx**. **High-Yield Clinical Pearls for NEET-PG:** * **Schedule G:** Drugs that must be taken under **medical supervision** but are not necessarily "prescription only" in the same sense as Schedule H (e.g., Metformin, Antihistamines). * **Schedule H1:** A sub-category introduced in 2013 to curb antibiotic resistance. It includes 3rd/4th gen Cephalosporins, Carbapenems, and certain habit-forming drugs (like Alprazolam). They require a separate register for sales. * **Schedule Y:** Guidelines for **Clinical Trials** and import/manufacture of new drugs. * **Schedule M:** Refers to **Good Manufacturing Practices (GMP)**.
Question 195: What is a specific inhibitor of alcohol dehydrogenase?
- A. Disulfiram
- B. Fomepizole (Correct Answer)
- C. Methyl alcohol
- D. Zolpidem
Explanation: **Explanation:** The metabolism of alcohols (Ethanol, Methanol, and Ethylene glycol) primarily occurs in the liver via two main enzymes: **Alcohol Dehydrogenase (ADH)** and **Aldehyde Dehydrogenase (ALDH)**. **1. Why Fomepizole is correct:** **Fomepizole** is a potent, competitive inhibitor of **Alcohol Dehydrogenase (ADH)**. By blocking this enzyme, it prevents the conversion of Methanol and Ethylene glycol into their toxic metabolites (Formaldehyde/Formic acid and Glycolic/Oxalic acid, respectively). It is the preferred antidote for Methanol and Ethylene glycol poisoning because it prevents metabolic acidosis and end-organ damage (like blindness or renal failure). **2. Why other options are incorrect:** * **Disulfiram:** It inhibits **Aldehyde Dehydrogenase (ALDH)**. This leads to the accumulation of Acetaldehyde if ethanol is consumed, causing the "Disulfiram-like reaction" (flushing, tachycardia, nausea). It is used in aversion therapy for chronic alcoholism. * **Methyl alcohol:** This is a substrate for ADH, not an inhibitor. It is metabolized into toxic formic acid. * **Zolpidem:** This is a non-benzodiazepine hypnotic (Z-drug) that acts on the $GABA_A$ receptor. It has no effect on alcohol-metabolizing enzymes. **High-Yield Clinical Pearls for NEET-PG:** * **Methanol Poisoning:** Characterized by "snowstorm vision" and optic disc hyperemia. * **Ethylene Glycol Poisoning:** Characterized by calcium oxalate crystals in urine (envelope-shaped) and acute tubular necrosis. * **Alternative Treatment:** If Fomepizole is unavailable, **Ethanol** can be used as an antidote because it has a higher affinity for ADH than methanol, acting as a competitive substrate. * **Cofactor:** Ethanol metabolism follows **zero-order kinetics** and requires $NAD^+$ as a cofactor.
Question 196: A 61-year-old male with a history of chronic arthritis complains of pronounced tinnitus. He also has some dizziness, with headache. Physical examination reveals some scattered petechiae over the upper extremities. A stool guaiac test result is positive. Which of the following drug toxicities best explains these findings?
- A. Penicillin
- B. Tetracycline
- C. Aspirin (Correct Answer)
- D. Chlorpromazine
Explanation: ### Explanation The clinical presentation described is a classic case of **Salicylism** (Aspirin toxicity). **1. Why Aspirin is the Correct Answer:** Aspirin (Acetylsalicylic acid) is a non-selective NSAID commonly used for chronic arthritis. Its toxicity manifests through a specific constellation of symptoms: * **Tinnitus and Dizziness:** Tinnitus is the most characteristic early sign of salicylate toxicity, caused by increased labyrinthine pressure and effect on the cochlear hair cells. * **Petechiae and Positive Stool Guaiac:** Aspirin causes irreversible inhibition of COX-1, leading to decreased Thromboxane A2 (TXA2) and impaired platelet aggregation. It also causes direct gastric mucosal irritation, leading to occult GI bleeding (positive stool guaiac). **2. Why Other Options are Incorrect:** * **Penicillin:** Toxicity typically involves hypersensitivity reactions (rashes, anaphylaxis) or, at very high doses, neurotoxicity (seizures), but not tinnitus or bleeding. * **Tetracycline:** Common side effects include GI upset, photosensitivity, and hepatotoxicity (especially in pregnancy), but it does not cause tinnitus or antiplatelet effects. * **Chlorpromazine:** This antipsychotic is associated with extrapyramidal symptoms, sedation, and cholestatic jaundice, but not the auditory or hemorrhagic symptoms seen here. **3. NEET-PG High-Yield Pearls:** * **Acid-Base Balance:** Early aspirin toxicity causes **Respiratory Alkalosis** (direct stimulation of the respiratory center). Late/Severe toxicity causes **Mixed Respiratory Alkalosis and Metabolic Acidosis** (Anion Gap). * **Management:** Treatment involves **Urinary Alkalinization** (using Sodium Bicarbonate) to enhance salicylate excretion (ion trapping). * **Triad of Salicylism:** Tinnitus, Headache, and Mental Confusion.
Question 197: Phase IV of clinical trials collect information specifically about which of the following?
- A. Drug efficacy
- B. Drug potency
- C. Drug toxicity (Correct Answer)
- D. Pharmacokinetics of the drug
Explanation: **Explanation:** **Phase IV Clinical Trials**, also known as **Post-Marketing Surveillance (PMS)**, are conducted after a drug has been approved and launched in the market. **Why "Drug Toxicity" is Correct:** While Phase I, II, and III trials involve a limited number of selected participants (usually <3,000), Phase IV monitors the drug in the general population (millions of users). This allows for the detection of **rare, long-term, or idiosyncratic adverse drug reactions (ADRs)** and chronic toxicities that were not evident during shorter, smaller pre-marketing trials. For example, the cardiotoxicity of Rofecoxib was identified only during Phase IV, leading to its withdrawal. **Why Other Options are Incorrect:** * **A. Drug Efficacy:** This is primarily established in **Phase III** (comparative trials) and **Phase II** (proof of concept). Phase IV looks at "effectiveness" in real-world settings, but its primary regulatory purpose is safety monitoring. * **B. Drug Potency:** This is a pharmacodynamic property determined during **pre-clinical animal studies** and early human trials; it is not the focus of Phase IV. * **C. Pharmacokinetics:** Basic PK parameters (Absorption, Distribution, Metabolism, Excretion) are established in **Phase I** (healthy volunteers). **High-Yield Clinical Pearls for NEET-PG:** * **Phase 0:** Microdosing studies to determine PK parameters (Human microdosing). * **Phase I:** Safety and Tolerability (usually in healthy volunteers, except for oncology drugs). * **Phase II:** Therapeutic dose-finding and efficacy (Small group of patients). * **Phase III:** Definitive assessment of efficacy and safety (Large multicentric RCTs). * **Black Box Warning:** Often added to a drug label as a result of Phase IV data.
Question 198: Fetal hydantoin syndrome is caused by which of the following agents?
- A. Phenytoin (Correct Answer)
- B. Alcohol
- C. Tetracycline
- D. Sodium valproate
Explanation: **Explanation:** **Fetal Hydantoin Syndrome (FHS)** is a specific pattern of birth defects caused by the teratogenic effects of **Phenytoin** (Option A), an antiepileptic drug belonging to the hydantoin class. The syndrome occurs due to the production of epoxide metabolites that cause oxidative stress in the developing fetus. **Why the other options are incorrect:** * **Alcohol (Option B):** Causes **Fetal Alcohol Syndrome (FAS)**, characterized by growth retardation, intellectual disability, and distinct facial features like a smooth philtrum, thin upper lip, and short palpebral fissures. * **Tetracycline (Option C):** Known for causing **discoloration of deciduous teeth** and enamel hypoplasia. It can also inhibit bone growth when taken during pregnancy. * **Sodium Valproate (Option D):** Associated with **Neural Tube Defects (NTDs)** like spina bifida (due to interference with folate metabolism) and "Fetal Valproate Syndrome," which presents with a characteristic "cupid’s bow" lip and prominent forehead. **Clinical Pearls for NEET-PG:** * **Features of FHS:** Microcephaly, hypoplastic nails and phalanges (highly characteristic), craniofacial abnormalities (cleft lip/palate, low-set ears), and cardiac defects. * **Drug of Choice for Epilepsy in Pregnancy:** Generally, **Levetiracetam** or **Lamotrigine** are preferred due to lower teratogenic risk. * **Prevention:** All women of childbearing age on AEDs should receive high-dose **Folic acid (5 mg/day)** to reduce the risk of malformations. * **Vitamin K:** Phenytoin can cause neonatal hemorrhage; thus, Vitamin K prophylaxis is essential for the newborn.
Question 199: Which chelating agent for copper, mercury, and lead poisoning is administered orally?
- A. BAL
- B. EDTA
- C. Penicillamine (Correct Answer)
- D. Succimer
Explanation: **Explanation:** The correct answer is **Penicillamine**. **1. Why Penicillamine is correct:** Penicillamine (D-dimethylcysteine) is a water-soluble degradation product of penicillin. It contains a sulfhydryl (-SH) group that forms stable, soluble complexes with divalent metal ions, which are then excreted in the urine. It is the drug of choice for **Wilson’s Disease** (Copper poisoning) and is also effective against **Mercury** and **Lead**. Crucially, it is well-absorbed from the GI tract, making it the preferred **oral** chelator for chronic heavy metal poisoning. **2. Why the other options are incorrect:** * **BAL (British Anti-Lewisite/Dimercaprol):** This is a lipid-soluble compound administered via **deep intramuscular (IM)** injection. It is used for Arsenic, Mercury, and Lead, but its oily vehicle (peanut oil) makes it painful and unsuitable for oral use. * **EDTA (Calcium Disodium Edetate):** This is highly polar and poorly absorbed from the gut. It must be administered **intravenously (IV)** or IM. It is primarily used for severe Lead poisoning. * **Succimer (DMSA):** While Succimer is indeed an **oral** chelator used for Lead, Mercury, and Arsenic, **Penicillamine** remains the classic textbook answer when specifically linking Copper, Mercury, and Lead in a single clinical profile (especially due to its unique role in Wilson's disease). *Note: In modern practice, Succimer is often preferred over Penicillamine for lead due to a better safety profile, but Penicillamine is the traditional multi-metal oral agent.* **3. High-Yield Clinical Pearls for NEET-PG:** * **Wilson’s Disease:** Penicillamine is the first-line chelator; Trientine is an alternative for those who cannot tolerate it. * **Adverse Effects:** Penicillamine can cause "Penicillamine-induced Systemic Lupus Erythematosus (SLE)," nephrotic syndrome, and skin elastosis. * **Contraindication:** Avoid BAL in patients with peanut allergies (due to the peanut oil vehicle). * **Iron Poisoning:** The specific chelator is **Desferrioxamine** (given parenterally) or **Deferasirox** (given orally).
Question 200: Which of the following is an antidote to acetaminophen poisoning?
- A. N-acetyl cysteine (Correct Answer)
- B. Atropine
- C. Flumazenil
- D. Naloxone
Explanation: **Explanation:** **1. Why N-acetyl cysteine (NAC) is correct:** Acetaminophen (Paracetamol) is primarily metabolized via glucuronidation and sulfation. However, a small portion is converted by **CYP2E1** into a highly reactive toxic metabolite called **NAPQI** (*N-acetyl-p-benzoquinone imine*). In overdose, glutathione stores are depleted, leading to NAPQI-induced hepatic necrosis. **N-acetyl cysteine (NAC)** acts as an antidote by: * Replenishing **glutathione** stores. * Acting as a glutathione substitute to directly conjugate and detoxify NAPQI. * It is most effective when administered within 8–10 hours of ingestion. **2. Why the other options are incorrect:** * **Atropine:** A muscarinic antagonist used for **organophosphate poisoning** or symptomatic bradycardia. * **Flumazenil:** A competitive benzodiazepine receptor antagonist used to reverse **benzodiazepine overdose**. * **Naloxone:** A pure opioid antagonist used for the emergency reversal of **opioid toxicity** (respiratory depression). **3. High-Yield Clinical Pearls for NEET-PG:** * **Rumack-Matthew Nomogram:** Used to determine the need for NAC treatment based on plasma acetaminophen levels vs. time since ingestion (only valid for single acute ingestions). * **Toxicity Marker:** NAPQI is the toxic metabolite; the liver is the primary organ affected (Centrilobular necrosis). * **NAC Administration:** Can be given IV or orally. The oral protocol typically lasts 72 hours, while the IV protocol (Acetadote) is 21 hours. * **Drug of Choice:** NAC is also used as a mucolytic in cystic fibrosis and to prevent contrast-induced nephropathy.
Practice by Chapter
Principles of Clinical Pharmacology
Practice Questions
Therapeutic Drug Monitoring
Practice Questions
Drug Toxicity and Overdose
Practice Questions
Antidotes and Their Applications
Practice Questions
Management of Drug Poisoning
Practice Questions
Drug-Induced Liver Injury
Practice Questions
Drug-Induced Kidney Injury
Practice Questions
Drug-Induced Blood Dyscrasias
Practice Questions
Drug-Induced QT Prolongation
Practice Questions
Pharmacovigilance
Practice Questions
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free